Key result
COVID-19 in athletes typically presents as mild illness but persistent respiratory symptoms delay return to sport.
Why the study?
Athletes with persistent cardiopulmonary symptoms after COVID-19 often have focus placed on cardiac complications, leaving pulmonary complications and physiological consequences needing summarization.
This review highlights the importance of assessing pulmonary complications, in addition to cardiac issues, in athletes experiencing prolonged symptoms following COVID-19 infection.
Answers are grounded in this paper and cite their sources.
Warrants pulmonary assessment in athletes with prolonged post-COVID symptoms; leaves open optimal return-to-sport guidance pending prospective trials.
Athletes typically experience a mild-to-moderate, self-limiting illness following infection with the novel severe acute respiratory syndrome coronavirus 2. Some athletes, however, can develop prolonged symptoms, with breathlessness, cough, and chest tightness impacting return to training and competition. In athletes with persistent cardiopulmonary symptoms following COVID-19, focus is usually placed on the identification and characterization of cardiac complications, such as myocarditis. In this review, we focus on summarizing the literature assessing pulmonary complications and physiological consequences associated with COVID-19 illness in athletes. The review also provides recommendations for clinical assessment of the athlete with pulmonary issues following COVID-19 and directions for future research.
No takes yet. Share an insight, caveat, or question.
Williams et al. (2022) conducted a review in COVID-19. COVID-19 infection was evaluated. Athletes typically experience a mild, self-limiting illness following COVID-19 infection, with rare development of pathological pulmonary disease, though persistent lower respiratory symptoms can prolong return to sport.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: